07UF47Z
Supplement Lymphatic, Right Lower Extremity to No Qualifier with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | 7 Lymphatic and Hemic Systems |
| Operation | U Supplement |
| Body Part | F Lymphatic, Right Lower Extremity |
| Approach | 4 Percutaneous Endoscopic |
| Device | 7 Autologous Tissue Substitute |
| Qualifier | Z No Qualifier |
Operation Definition
Putting in or on biological or synthetic material that physically reinforces and/or augments the function of a portion of a body part
Procedure Overview
This family covers procedures where a surgeon places biological or synthetic material onto or into a structure of the lymphatic and hemic system to reinforce it or bolster a function that has been weakened, most often after injury. The leading example is splenic salvage surgery: when the spleen has been lacerated in blunt abdominal trauma, wrapping it in absorbable mesh compresses the injured tissue and supports it while it heals, allowing the surgeon to avoid removing the organ altogether. Patients benefit because the spleen filters blood and helps fight certain bacteria, so keeping it intact lowers the lifetime risk of severe infection that follows a splenectomy.
The material itself is not doing the healing directly; it is holding tissue together and adding structural support so that the body's own repair processes can proceed without the organ falling apart or re-bleeding. Outside of splenic trauma, this family sees limited use elsewhere in the lymphatic system, since lymph nodes and channels are rarely reinforced with an implanted product.
Anatomy & Axis Detail
Lymphatic, Right Lower Extremity
Lymphatic channels of the right lower extremity run alongside the superficial and deep venous systems, draining the leg and foot toward the inguinal nodes, and they are frequently compromised by prior node dissection, chronic venous disease, or filarial or congenital lymphedema. Supplementation here typically involves microsurgical techniques such as vascularized lymph node transfer or the placement of a biologic conduit to augment impaired drainage and reduce limb swelling. Because outcomes depend on restoring flow across a functional deficit rather than simply excising diseased tissue, documentation should describe the specific level of the extremity treated and the material used, distinguishing this reconstructive approach from procedures aimed at removing or restricting lymphatic tissue.
Approach: Percutaneous Endoscopic
Percutaneous Endoscopic combines a puncture through skin or mucous membrane with insertion of an endoscope to visualize the procedure internally, as in laparoscopic cholecystectomy. It is distinguished from plain Percutaneous by the presence of scope-guided visualization, and from Via Natural or Artificial Opening Endoscopic by its route being a new puncture rather than an existing orifice or stoma.
Device: Autologous Tissue Substitute
Autologous Tissue Substitute identifies a device value where material harvested from the patient's own body, such as an autograft, is used to replace or reconstruct a body part. Its defining feature is tissue origin from the patient, setting it apart from Nonautologous Tissue Substitute, sourced from a donor or animal, and Synthetic Substitute, made of manufactured material.
Coding & Documentation
A coder should look for documentation that a mesh, wrap, or similar reinforcing material was left in place around an existing structure, most commonly the spleen, distinguishing it from a laceration that was simply sutured closed. The operative note needs to specify both the material used and that it augments rather than replaces the organ. The most frequent error is defaulting to Repair whenever a splenic injury is fixed surgically, when the presence of a retained mesh wrap actually calls for Supplement with the correct device value recorded.